[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369382-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369382-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","sim2-associated-with-clinicopathologic-features-promotes-the-malignant-biological-behaviors-of-endometrial-carcinoma-cells","SIM2 - associated with clinicopathologic features, promotes the malignant biological behaviors of endometrial carcinoma cells","","Endometrial carcinoma (EC) threatens women’s health, making prognostic biomarkers and therapeutic targets crucial to improve survival. This study identifies key regulators in EC progression and investigates the biological roles of SIM bHLH transcription factor 2 (SIM2). Gene expression profiles and clinical data were retrieved from TCGA and GEO, using differential expression and WGCNA to find EC-associated genes. LASSO and Cox analyses screened 13 prognostic genes and built a risk model predicting patient outcomes, with immune microenvironment differences between risk groups. SIM2 was overexpressed in EC tissues, correlated with poor prognosis, and functionally suppressed EC viability, induced cell-cycle arrest, and promoted apoptosis, including reduced Cyclin D1 and CDK4 and increased cleaved caspase-3. In vivo, SIM2 silencing reduced metastatic potential, supporting SIM2 as a diagnostic and prognostic biomarker and therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/sim2-associated-with-clinicopathologic-features-promotes-the-malignant-biological-behaviors-of-endometrial-carcinoma-cells/369382/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/sim2-associated-with-clinicopathologic-features-promotes-the-malignant-biological-behaviors-of-endometrial-carcinoma-cells/369382.png","ImageObject",300,407,{"name":42,"@type":43},"Mia  ","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main goal of this study on SIM2 in endometrial carcinoma?","Question",{"text":63,"@type":64},"The study aimed to identify key regulators in EC progression and to determine the biological functions of SIM2 in EC development and malignancy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were prognostic genes and the risk model constructed?",{"text":68,"@type":64},"Gene expression profiles and clinical data from TCGA and GEO were analyzed with differential expression and WGCNA. LASSO and Cox regression then screened 13 prognostic genes to build a risk model predicting clinical outcomes.",{"name":70,"@type":61,"acceptedAnswer":71},"What effects did SIM2 knockdown and overexpression have on endometrial carcinoma cells?",{"text":72,"@type":64},"SIM2 depletion inhibited EC cell viability, induced cell-cycle arrest, and promoted apoptosis, including increased cleaved caspase-3 and decreased Cyclin D1 and CDK4. SIM2 overexpression produced opposite effects.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369382,1790621958,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687207024478,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Nie and Chen BMC Cancer (2025) 25:666 [https://doi.org/10.1186/s12885-025-14077-0](https://doi.org/10.1186/s12885-025-14077-0)  \nBMC Cancer  \n RESEARCH Open Access  \nSIM2, associated with clinicopathologic   features, promotes the malignant biological behaviors of endometrial carcinoma cells  \nHua Nie 1,2 and Yu Chen1,2*  \nAbstract  \nBackground Endometrial carcinoma (EC) poses a significant threat to women’s health. Identifying effective prognostic biomarkers and therapeutic targets is essential for improving survival rates in EC patients. This study aimed to identify key regulators involved in EC progression and investigate the biological functions of SIM bHLH transcription factor 2 (SIM2) in EC.  \nMethods Gene expression profiles and clinical data from EC and control samples were retrieved from theTCGA and GEO databases. Differential expression analysis and weighted gene co-expression network analysis (WGCNA) were used to identify genes associated with EC tumorigenesis and progression. The least absolute shrinkage and selection operator (LASSO) method was applied to further screen prognostic genes and construct a prognostic risk model. The expression and biological function of SIM2 were analyzed using the GEPIA, HPA, and LinkedOmics databases. SIM2 knockdown and overexpression models were established in EC cell lines, and their function was validated through qRT-PCR, CCK-8, flow cytometry, and western blot. Additionally, an in vivo lung/liver metastasis model was employed to further validate the cancer-promoting properties of SIM2 in EC.  \nResults WGCNA identified 343 EC-related genes. Cox regression analysis and LASSO were further applied to identify 13 prognostic genes, leading to the development of a robust prognostic risk model that effectively predicted EC patients’ clinical outcomes. Significant differences in the tumor immune microenvironment were observed between the high-and low-risk groups. Among these 13 genes, SIM2 was significantly overexpressed in EC tissues, and its high expression was associated with poor prognosis in EC patients. SIM2 depletion inhibited EC cell viability, induced cell cycle arrest, and promoted apoptosis. Additionally, SIM2 knockdown increased the expression of cleaved caspase-3 and reduced the levels of Cyclin D1 and CDK4 proteins, while SIM2 overexpression showed the opposite effects. In vivo, silencing SIM2 notably suppressed the metastatic potential of EC cells.  \nConclusion SIM2 serves as both a biomarker and a therapeutic target for EC diagnosis and prognosis prediction, which positively modulates the malignant phenotypes of EC cells.  \nKeywords Endometrial carcinoma, Prognosis, WGCNA, LASSO, SIM2  \n*Correspondence: Yu Chen [hustchenyu11@163.com](hustchenyu11@163.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[.](http://creativecommons.org/licenses/by-nc-nd/4.0/.)  \nNie and Ch","cbCaib7eCZRi4ILw","https://ap.wps.com/l/cbCaib7eCZRi4ILw","pdf",9156342,14,"English","# Abstract\n# Background\n# Introduction\n# Methods\n# Results\n# Conclusion","[{\"question\":\"What was the main goal of this study on SIM2 in endometrial carcinoma?\",\"answer\":\"The study aimed to identify key regulators in EC progression and to determine the biological functions of SIM2 in EC development and malignancy.\"},{\"question\":\"How were prognostic genes and the risk model constructed?\",\"answer\":\"Gene expression profiles and clinical data from TCGA and GEO were analyzed with differential expression and WGCNA. LASSO and Cox regression then screened 13 prognostic genes to build a risk model predicting clinical outcomes.\"},{\"question\":\"What effects did SIM2 knockdown and overexpression have on endometrial carcinoma cells?\",\"answer\":\"SIM2 depletion inhibited EC cell viability, induced cell-cycle arrest, and promoted apoptosis, including increased cleaved caspase-3 and decreased Cyclin D1 and CDK4. SIM2 overexpression produced opposite effects.\"}]","SIM2 - associated with clinicopathologic features, promotes the malignant biological behaviors of endometrial carcinoma cells | PDF",1790182316,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c055fc5b56a2c8c3c691d89c590a8c64.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d5562f64d7e2bdd166e311b2767c69b6.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f1272e1bd31882bd9c56c7de378616a4.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8609c5f34108ab684411e713f878ac5f.webp",980,1301]